Literature DB >> 22328635

Critical care in emergency department: massive haemorrhage in trauma.

Tushar Mahambrey1, Katherine Pendry, Alexandra Nee, Samantha Bonney, Patrick A Nee.   

Abstract

Inadequate resuscitation of major haemorrhage is an important cause of avoidable death in severely injured patients. Early recognition of blood loss, control of bleeding and restoration of circulating volume are critical to the management of trauma shock, and transfusion of blood components is a key intervention. Vital signs may be inadequate to determine the need for transfusion, and resuscitation regimens targeting vital signs may be harmful in the context of uncontrolled bleeding. This article addresses current concepts in haemostatic resuscitation. Recent guidelines on the diagnosis and treatment of coagulopathy in major trauma, and the role of component and adjuvant therapies, are considered. Finally, the potential role of thromboelastography and rotational thromboelastometry are discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22328635     DOI: 10.1136/emermed-2011-201061

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  3 in total

Review 1.  Point of care and factor concentrate-based coagulation algorithms.

Authors:  Oliver M Theusinger; Philipp Stein; Jerrold H Levy
Journal:  Transfus Med Hemother       Date:  2015-03-20       Impact factor: 3.747

2.  Effect of liposome-encapsulated hemoglobin resuscitation on proteostasis in small intestinal epithelium after hemorrhagic shock.

Authors:  Geeta Rao; Vivek R Yadav; Shanjana Awasthi; Pamela R Roberts; Vibhudutta Awasthi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-06-10       Impact factor: 4.052

3.  Traumatic Abdominal Solid Organ Injury Patients Might Benefit From Thromboelastography-Guided Blood Component Therapy.

Authors:  Hao Wang; Richard D Robinson; Jessica L Phillips; Andrew Ryon; Scott Simpson; Jonathan R Ford; Johnbosco Umejiego; Therese M Duane; Bradley Putty; Nestor R Zenarosa
Journal:  J Clin Med Res       Date:  2017-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.